Pharmacology, Toxicology and Pharmaceutical Science
Chronic Lymphatic Leukemia
100%
Acute Myeloid Leukemia
30%
Chemotherapy
29%
microRNA
29%
Fludarabine
24%
7 Hydroxystaurosporine
21%
Nerve Growth Factor
21%
Nicotinamide Phosphoribosyltransferase
21%
Catalase
18%
Nucleoside Analog
16%
Glutathione Peroxidase
16%
Histone Deacetylase
15%
Ibrutinib
14%
Neoplasm
14%
Diseases
14%
Hydrogen Peroxide
14%
Glioblastoma
14%
Oxaliplatin
14%
Gene Delivery
14%
Onalespib
14%
Clinical Trial
12%
Bruton Tyrosine Kinase Inhibitor
12%
Malignant Neoplasm
11%
Venetoclax
11%
Phosphotransferase
10%
Temozolomide
10%
Mouse Model
10%
Cytotoxicity
9%
B Cell Lymphoma
9%
Neurotrophin
9%
Leukemia
8%
Murine
8%
Bruton Tyrosine Kinase
7%
Vidarabine
7%
Sapacitabine
7%
Cyclin Dependent Kinase 2
7%
Selinexor
7%
Gilteritinib
7%
Pharmacodynamics
7%
Endonuclease
7%
Nicotinamide Adenine Dinucleotide
7%
DNA Topoisomerase (ATP Hydrolysing)
7%
Pheochromocytoma
7%
Chemoradiation Therapy
7%
microRNA 182
7%
Long Untranslated RNA
7%
CD135 Antigen
7%
Toll Like Receptor 7
7%
Deubiquitinase
7%
Cycline
7%
Keyphrases
Chronic Lymphocytic Leukemia
75%
Acute Myeloid Leukemia
31%
DNA Damage
29%
MicroRNA
28%
DNA Repair
22%
Chronic Lymphocytic Leukemia Cells
22%
Cell Death
17%
Glutathione Peroxidase (GSH-Px)
17%
Catalase
16%
Nucleoside Analogues
15%
Histone Deacetylases
15%
Onalespib
14%
Nerve Growth Factor
14%
7-hydroxystaurosporine
14%
KPT-9274
14%
DNA Repair Capacity
13%
Survival Pathways
13%
PC12 Cells
10%
Cell Cycle Progression
10%
Response to Chemotherapy
10%
Hematological Malignancies
10%
Dysregulation
10%
Homologous Recombination Repair
10%
Sigma Phase
10%
Bromodomain-containing Protein 4 (BRD4)
10%
Histone Deacetylase 1 (HDAC1)
9%
Fludarabine
9%
B Cells
9%
Histone Deacetylase Inhibitor (HDACi)
9%
Apoptosis
9%
Bruton Tyrosine Kinase Inhibitor
9%
Phosphate
9%
In Vivo Efficacy
9%
RAD51
8%
Checkpoint Kinase 1 (CHK1)
8%
Cell Cycle Checkpoint
8%
Long Non-coding RNA (LncRNA)
8%
S-phase Arrest
8%
Malignant Glioma
8%
CLL Cells
8%
Cyclin-dependent Kinase 9 (CDK9)
8%
Pathobiology
8%
Chemotherapy
8%
Glioma Stem Cells
8%
UCN-01
8%
Neurotrophins
8%
Antioxidant Gene Expression
8%
Alkylating Agents
7%
Prognostic Indicator
7%
Mouse Model
7%
Biochemistry, Genetics and Molecular Biology
MicroRNA
44%
Programmed Cell Death
39%
Nucleoside Analog
37%
S Phase
23%
Fludarabine
21%
DNA Damage
19%
DNA Repair
18%
Myeloid
17%
Histone Deacetylase
17%
Catalase
15%
Cell Death
14%
Nerve Growth Factor
14%
Glutathione Peroxidase
14%
Homologous Recombination
14%
Nicotinamide Phosphoribosyltransferase
14%
Phosphotransferase
13%
Kinase
13%
Clinical Trial
12%
BRD4
12%
Cytarabine
11%
Cell Cycle Progression
11%
P53
11%
Protein Kinase B
11%
Promoter Region
10%
Epigenetics
10%
Gemcitabine
10%
Cell Cycle Checkpoint
10%
Drug Resistance
10%
Protein Kinase
10%
Messenger RNA
9%
Enzyme
9%
Zebra fish
9%
DNA Synthesis
9%
Cytotoxicity
9%
Antioxidant Enzyme
9%
Hydrogen Peroxide
9%
TRAIL
9%
Slice Culture
8%
Recombination Repair
8%
Myc
8%
Immunity
8%
Bruton Tyrosine Kinase
8%
HDAC1
8%
P21-Activated Kinases
8%
P73
8%
Oxidative Stress
8%
Anticancer
8%
Methylation
8%
Cell Cycle
8%
Protein Expression
8%
